LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 3 of 15: Cell count and relative growth within biological replicate 3. - Dataset (ID:20239)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | R406 | 0.37 | uM | LJP6 | 1 | C16 | 72 | hr | 1401 | 4063 | 4223 | 0.9621 | 0.9433 |
| SK-BR-3 | R406 | 0.37 | uM | LJP6 | 2 | C16 | 72 | hr | 1401 | 4336 | 4223 | 1.0267 | 1.0400 |
| SK-BR-3 | R406 | 0.37 | uM | LJP6 | 3 | C16 | 72 | hr | 1401 | 3938 | 4223 | 0.9325 | 0.8990 |
| SK-BR-3 | Pictilisib | 0.37 | uM | LJP6 | 1 | D22 | 72 | hr | 1401 | 1994 | 4223 | 0.4722 | 0.2100 |
| SK-BR-3 | Pictilisib | 0.37 | uM | LJP6 | 2 | D22 | 72 | hr | 1401 | 1792 | 4223 | 0.4243 | 0.1384 |
| SK-BR-3 | Pictilisib | 0.37 | uM | LJP6 | 3 | D22 | 72 | hr | 1401 | 1808 | 4223 | 0.4281 | 0.1441 |
| SK-BR-3 | Gefitinib | 0.37 | uM | LJP6 | 1 | N10 | 72 | hr | 1401 | 3235 | 4223 | 0.7660 | 0.6498 |
| SK-BR-3 | Gefitinib | 0.37 | uM | LJP6 | 2 | N10 | 72 | hr | 1401 | 2918 | 4223 | 0.6910 | 0.5375 |
| SK-BR-3 | Gefitinib | 0.37 | uM | LJP6 | 3 | N10 | 72 | hr | 1401 | 3128 | 4223 | 0.7407 | 0.6119 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP5 | 1 | O04 | 72 | hr | 1401 | 1204 | 4223 | 0.2851 | -0.0700 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP5 | 2 | O04 | 72 | hr | 1401 | 1610 | 4223 | 0.3812 | 0.0739 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP5 | 3 | O04 | 72 | hr | 1401 | 1653 | 4223 | 0.3914 | 0.0891 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP6 | 1 | O04 | 72 | hr | 1401 | 1573 | 4223 | 0.3725 | 0.0608 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP6 | 2 | O04 | 72 | hr | 1401 | 1393 | 4223 | 0.3299 | -0.0030 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP6 | 3 | O04 | 72 | hr | 1401 | 1393 | 4223 | 0.3299 | -0.0030 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP5 | 1 | E04 | 72 | hr | 1401 | 2855 | 4223 | 0.6761 | 0.5151 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP5 | 2 | E04 | 72 | hr | 1401 | 2900 | 4223 | 0.6867 | 0.5311 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP5 | 3 | E04 | 72 | hr | 1401 | 3207 | 4223 | 0.7594 | 0.6399 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP6 | 1 | C04 | 72 | hr | 1401 | 3104 | 4223 | 0.7350 | 0.6034 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP6 | 2 | C04 | 72 | hr | 1401 | 2985 | 4223 | 0.7068 | 0.5612 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP6 | 3 | C04 | 72 | hr | 1401 | 3006 | 4223 | 0.7118 | 0.5687 |
| SK-BR-3 | GSK1904529A | 0.37 | uM | LJP6 | 1 | H22 | 72 | hr | 1401 | 4194 | 4223 | 0.9931 | 0.9897 |
| SK-BR-3 | GSK1904529A | 0.37 | uM | LJP6 | 2 | H22 | 72 | hr | 1401 | 3850 | 4223 | 0.9117 | 0.8678 |
| SK-BR-3 | GSK1904529A | 0.37 | uM | LJP6 | 3 | H22 | 72 | hr | 1401 | 4096 | 4223 | 0.9699 | 0.9550 |
| SK-BR-3 | Omipalisib | 0.37 | uM | LJP6 | 1 | N04 | 72 | hr | 1401 | 1211 | 4223 | 0.2868 | -0.0675 |